Oppenheimer Maintains ESSA Pharma(EPIX.US) With Buy Rating, Maintains Target Price $17
Oppenheimer Sticks to Their Buy Rating for ESSA Pharma (EPIX)
Piper Sandler Maintains ESSA Pharma(EPIX.US) With Buy Rating, Maintains Target Price $15
JonesTrading Maintains ESSA Pharma(EPIX.US) With Buy Rating, Maintains Target Price $18
JonesTrading Maintains ESSA Pharma(EPIX.US) With Buy Rating, Maintains Target Price $18
Buy Rating Affirmed on ESSA Pharma Amid Promising MCRPC Therapy Data and Upcoming ESMO Conference Insights
Piper Sandler Maintains ESSA Pharma(EPIX.US) With Buy Rating, Maintains Target Price $15
Piper Sandler Maintains ESSA Pharma(EPIX.US) With Buy Rating, Maintains Target Price $15
ESSA Pharma (EPIX) Receives a Buy From Oppenheimer
Piper Sandler Maintains ESSA Pharma(EPIX.US) With Buy Rating, Maintains Target Price $15
Piper Sandler Sticks to Its Buy Rating for ESSA Pharma (EPIX)
JonesTrading Maintains ESSA Pharma(EPIX.US) With Buy Rating, Maintains Target Price $18
ESSA Pharma Analyst Ratings
Oppenheimer Sticks to Its Buy Rating for ESSA Pharma (EPIX)
Buy Rating Endorsed for ESSA Pharma on Robust Pipeline and Market Expansion Potential
Analysts Offer Insights on Healthcare Companies: ESSA Pharma (EPIX) and Rocket Pharmaceuticals (RCKT)
Analysts Are Bullish on Top Healthcare Stocks: Puma Biotechnology (PBYI), ESSA Pharma (EPIX)
Analysts Offer Insights on Healthcare Companies: Envista Holdings (NVST), AbbVie (ABBV) and ESSA Pharma (EPIX)
Analysts Have Conflicting Sentiments on These Healthcare Companies: Phreesia (PHR), RegenXBio (RGNX) and ESSA Pharma (EPIX)
Oppenheimer Reiterates Outperform on ESSA Pharma, Maintains $17 Price Target